Human prothrombin complex(Hebei Daan Pharmaceutical)

人凝血酶原复合物（河北大安制药）

Report date: 2022/01/14 13:23:58

Base Information

Drug NameHuman prothrombin complex(Hebei Daan Pharmaceutical)
Drug Alias Name人凝血酶原复合物
ClassificationBiologics > Blood components
Mechanisms of ActionCoagulation factor VII modulatorsCoagulation factor X modulatorsCoagulation factor IX modulators +[4] 
TargetsCoagulation factor VIICoagulation factor XCoagulation factor IX +[4] 
Therapy Area/IndicationsHemorrhageHemophilia B
Global Approved IndicationsHemorrhage
Approved Indications in ChinaHemorrhage
Original Approved Country/TerritoryMainland China
Original Approved Date2020/01/01
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesHebei Daan Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesHebei Daan Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsHemorrhage
Inactive IndicationsHemophilia B

Other Information

ATC CodeB02BD01
Related LinksN/A